CN102924362B - 一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 - Google Patents
一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 Download PDFInfo
- Publication number
- CN102924362B CN102924362B CN201210419628.6A CN201210419628A CN102924362B CN 102924362 B CN102924362 B CN 102924362B CN 201210419628 A CN201210419628 A CN 201210419628A CN 102924362 B CN102924362 B CN 102924362B
- Authority
- CN
- China
- Prior art keywords
- pyrryl
- cyclopentano
- amino
- hydrogen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- -1 amine hydrochloride Chemical class 0.000 title abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- 239000004094 surface-active agent Substances 0.000 claims abstract description 31
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011591 potassium Substances 0.000 claims abstract description 13
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 13
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 32
- 150000001412 amines Chemical class 0.000 claims description 19
- 238000000605 extraction Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000001953 recrystallisation Methods 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 3
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 239000011874 heated mixture Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002912 waste gas Substances 0.000 abstract 1
- 239000002351 wastewater Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000006277 sulfonation reaction Methods 0.000 description 6
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 5
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 229960000346 gliclazide Drugs 0.000 description 4
- 238000010907 mechanical stirring Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940127017 oral antidiabetic Drugs 0.000 description 3
- 239000003538 oral antidiabetic agent Substances 0.000 description 3
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101100323029 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) alc-1 gene Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210419628.6A CN102924362B (zh) | 2012-10-26 | 2012-10-26 | 一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210419628.6A CN102924362B (zh) | 2012-10-26 | 2012-10-26 | 一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102924362A CN102924362A (zh) | 2013-02-13 |
CN102924362B true CN102924362B (zh) | 2014-12-03 |
Family
ID=47639324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210419628.6A Expired - Fee Related CN102924362B (zh) | 2012-10-26 | 2012-10-26 | 一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102924362B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601666B (zh) * | 2013-11-28 | 2015-09-02 | 遵义医学院 | 八氢环戊烷[c]吡咯的制备方法 |
CN106588746B (zh) * | 2016-11-25 | 2019-08-13 | 盘锦格林凯默科技有限公司 | 格列齐特侧链的制备方法和格列齐特的制备方法 |
CN110372568A (zh) * | 2019-08-22 | 2019-10-25 | 山东海佑福瑞达制药有限公司 | 一种格列齐特中间体的结晶及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006298864A (ja) * | 2005-04-22 | 2006-11-02 | Toyo Beauty Kk | ジェミニ型界面活性剤 |
CN100591667C (zh) * | 2008-03-11 | 2010-02-24 | 浙江大学 | N-氨基-1,2-环戊烷二甲酰亚胺及其制备方法 |
CN102746243B (zh) * | 2012-07-23 | 2014-12-10 | 浙江常山科润化学有限公司 | 一种2-(2-羟基-3-氯乙酰基-5-甲基苯基)苯并三氮唑的制备方法 |
-
2012
- 2012-10-26 CN CN201210419628.6A patent/CN102924362B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102924362A (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113004142B (zh) | 一种2,4,5-三氟苯乙酸新型制备方法 | |
CN103242197B (zh) | 一种紫外吸收剂中间体依托立林的制备方法 | |
CN102924362B (zh) | 一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 | |
CN105254575B (zh) | 一种磺胺嘧啶的合成方法 | |
CN101891621A (zh) | 3-乙氧基-4-乙氧羰基苯乙酸的合成方法 | |
CN102942509B (zh) | 一种酚磺乙胺的合成方法 | |
CN104059023A (zh) | 维生素b1关键中间体2-甲基-4-氨基-5-氨基甲基嘧啶的环保制备方法 | |
CN101607971A (zh) | 9-[2-(二乙氧基膦酰甲氧基)乙基]腺嘌呤的合成方法 | |
CN107936045B (zh) | 一种高纯度氟比洛芬已知杂质的制备方法 | |
CN111116493B (zh) | 一种制备Apabetalone的方法、中间体及其中间体的制备方法 | |
CN106478422A (zh) | 一种对硝基苯乙酸的制备方法 | |
CN110590702B (zh) | 一种制备2-巯基苯并噻唑的新方法 | |
CN102503806A (zh) | 一种1,3,5,7-四(4-丙烯酸-苯基)金刚烷化合物的合成方法 | |
CN107382690B (zh) | 一种盐酸曲美他嗪中间体的制备方法 | |
CN102816115B (zh) | 一种羟基取代-3,4-二氢-2(1h)-喹啉酮类化合物的合成方法 | |
CN100465149C (zh) | 氯代苯乙酸的制造方法 | |
CN104211663A (zh) | 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用 | |
CN103910695B (zh) | 一种非布索坦的合成方法 | |
CN102603777A (zh) | 一种纳斯特试剂的制备方法 | |
CN102964300B (zh) | 一种2-(3ˊ-喹啉基)烯丙醇化合物的合成方法 | |
CN102702114B (zh) | 一种硝基乳清酸的制备方法 | |
CN109053780B (zh) | 一种抗肿瘤药物Acalabrutinib关键中间体的制备方法 | |
CN113527208A (zh) | 一步法制备2-氯-4-(1h-吡唑-3-基)苯甲腈的方法 | |
CN106673978A (zh) | 3,5‑二氯‑2‑戊酮的连续化合成方法 | |
CN105399688A (zh) | 一种吉非替尼的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171221 Address after: 313000 Zhejiang Province, Huzhou city Wuxing District Road No. 1188 district headquarters free port B building 14 Building 1403 room Patentee after: Zhejiang creation Intellectual Property Service Co.,Ltd. Address before: 310014 Hangzhou city in the lower reaches of the city of Zhejiang Wang Road, No. 18 Patentee before: Zhejiang University of Technology |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191120 Address after: 215100 Jiangsu province Suzhou Wuzhong Economic Development Zone the River Street Wuzhong Road No. 1368 Building 1 Patentee after: Suzhou Wei you Intellectual Property Operation Co.,Ltd. Address before: 313000 Room 1403, 14th Floor, Building B, Freeport, Headquarters 1188 District Fulu Road, Wuxing District, Huzhou City, Zhejiang Province Patentee before: Zhejiang creation Intellectual Property Service Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141203 |
|
CF01 | Termination of patent right due to non-payment of annual fee |